Z-0607-2018 Class II Terminated

Recalled by Sanofi Genzyme — Cambridge, MA

Recall Details

Product Type
Devices
Report Date
February 21, 2018
Initiation Date
December 11, 2017
Termination Date
April 3, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
12,380 units

Product Description

Synvisc-One ¿ (hylan G-F 20), 6mL delivered from a 10mL syringe Product Usage: A elastoviscous high molecular weight fluid containing hylan A and hylan B polymers produced from chicken combs. Synvisc-One is administered as a single intra-articular injection. Synvisc-One is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen.

Reason for Recall

Contamination with Methylbacterium thiocyanatum

Distribution Pattern

US Nationwide distribution(36 states)

Code Information

Lot Number: 7RSL021 Expiration Date: 2020-05-31